نتائج البحث - Hatice Bolek
- يعرض 1 - 10 نتائج من 10
-
1
-
2
Confirmation of Large Language Models in Head and Neck Cancer Staging حسب Mehmet Kayaalp, Hatice Bölek, Hatime Arzu Yaşar
الحاوية / القاعدة Diagnostics (2025-09-01)احصل على النص الكامل
مقال -
3
The prognostic value of elimination rate constant K score of prostate-specific antigen in metastatic castration-resistant prostate cancer patients treated with docetaxel حسب Satı Coşkun Yazgan, Abdulkadir Sarı, Hatice Bölek, Emre Yekedüz, Yüksel Ürün
الحاوية / القاعدة Prostate International (2025-06-01)احصل على النص الكامل
مقال -
4
Perceptions and Expectations: A Study on Prognostic Perception and Quality of Life in Patients With Metastatic Renal and Bladder Cancer حسب Hatice Bolek, Cagatay Arslan, Mert Basaran, İrfan Cicin, Mustafa Ozguroglu, Deniz Tural, Yüksel Ürün
الحاوية / القاعدة JCO Global Oncology (2024-08-01)احصل على النص الكامل
مقال -
5
Menopausal Status at Diagnosis is a Prognostic Indicator in Patients who are Operated for Uterine Carcinosarcoma حسب Hatice Bölek, Merih Yalçıner, Serhat Sekmek, Furkan Ceylan, Orhun Akdoğan, Doğan Uncu, Ozan Yazıcı, Elif Berna Köksoy
الحاوية / القاعدة Ankara Üniversitesi Tıp Fakültesi Mecmuası (2025-06-01)احصل على النص الكامل
مقال -
6
Real-world treatment patterns and survival outcomes in metastatic head and neck adenoid cystic carcinoma حسب Hatice Bölek, Mehmet Kayaalp, Taha Koray Şahin, Osman Talha Doğan, Seher Yüksel, Sumerya Duru Birgi, Ibrahim Halil Gullu, Mustafa Kürşat Gökcan, Sercan Aksoy, Hatime Arzu Yaşar
الحاوية / القاعدة BMC Cancer (2025-09-01)احصل على النص الكامل
مقال -
7
Navigating second-line therapy in metastatic renal cell carcinoma: a comparative analysis of immune checkpoint inhibitors and tyrosine kinase inhibitors: a study of Turkish Oncolog... حسب Musa Barış Aykan, Hatice Bölek, Emre Yekedüz, Elif Sertesen, Deniz Tural, Cengiz Karaçin, Mehmet Ali Nahit Şendur, Gökhan Uçar, Çağatay Arslan, Selver Işık, Saadet Sim, Özlem Nuray Sever, Bekir Hacıoğlu, Sema Sezgin Göksu, Mustafa Özgüroğlu, Nuri Karadurmuş, Yüksel Ürün
الحاوية / القاعدة Therapeutic Advances in Medical Oncology (2025-04-01)احصل على النص الكامل
مقال -
8
Sunitinib in metastatic renal cell carcinoma: clinical outcomes across risk groups in a Turkish Oncology Group Kidney Cancer Consortium حسب Hatice Bolek, Omer Faruk Kuzu, Elif Sertesen Camoz, Saadet Sim, Serhat Sekmek, Hilal Karakas, Selver Isık, Murad Guliyev, Aysun Fatma Akkus, Deniz Tural, Cagatay Arslan, Sema Sezin Goksu, Ozlem Nuray Sever, Nuri Karadurmus, Cengiz Karacin, Mehmet Ali Nahit Sendur, Emre Yekedüz, Yuksel Urun
الحاوية / القاعدة Cancer Communications (2025-05-01)احصل على النص الكامل
مقال -
9
Impact of first-line tyrosine kinase inhibitor selection on survival outcomes with second-line nivolumab in metastatic renal cell carcinoma حسب Omer Faruk Kuzu, Hatice Bolek, Elif Sertesen Camoz, Hilal Karakas, Serhat Sekmek, Saadet Sim, Selver Isık, Murat Günaltılı, Aysun Fatma Akkus, Deniz Tural, Cagatay Arslan, Sema Sezin Goksu, Ozlem Nuray Sever, Cengiz Karacin, Mehmet Ali Nahit Sendur, Nuri Karadurmus, Emre Yekedüz, Yüksel Ürün
الحاوية / القاعدة BMC Cancer (2025-07-01)احصل على النص الكامل
مقال -
10
Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors—Data From the ARON-1 Study حسب Francesco Massari, Matteo Rosellini, Bohuslav Melichar, Enrique Grande, Maria T. Bourlon, Haoran Li, Ondřej Fiala, Se Hoon Park, Maria José Juan Fita, Tarek Taha, Javier Molina-Cerrillo, Daniele Santini, Alfonso Gómez de Liañ, Thomas Büttner, Sarah Scagliarini, Ray Manneh Kopp, Annalisa Zeppellini, Marwan Ghosn, Vincenza Conteduca, Hatice Bölek, Alessandro Rizzo, Jawaher Ansari, Veronica Mollica, Anca Zgura, Alessandra Filosa, Ahmet Yildirim, Umut Akova, Fernando Sabino Marques Monteiro, Sebastiano Buti, Andrey Soares, Mehmet Asim Bilen, Yüksel Ürün, Matteo Santoni
الحاوية / القاعدة JCO Global Oncology (2025-10-01)احصل على النص الكامل
مقال
